VM
VHCP Management Portfolio holdings
AUM
$93M
This Quarter Return
+22.82%
1 Year Return
-10.46%
3 Year Return
+232.85%
5 Year Return
–
10 Year Return
–
AUM
$354M
AUM Growth
+$354M
(-18%)
Cap. Flow
-$202M
Cap. Flow
% of AUM
-56.9%
Top 10 Holdings %
Top 10 Hldgs %
85.92%
Holding
20
New
1
Increased
1
Reduced
3
Closed
2
Top Buys
| 1 |
ORKA
Oruka Therapeutics, Inc. Common Stock
ORKA
|
$12.4M |
| 2 |
Lipocine
LPCN
|
$5.15M |
Top Sells
| 1 |
JUNO
Juno Therapeutics, Inc.
JUNO
|
$88.5M |
| 2 |
BioCryst Pharmaceuticals
BCRX
|
$20.5M |
| 3 |
DYAX
DYAX CORPORATION
DYAX
|
$16.8M |
| 4 |
TherapeuticsMD
TXMD
|
$5.12M |
Sector Composition
| 1 | Healthcare | 58.53% |
